The Utility of Telemedicine in the Management of Migraine

Status Completed

Clinical Trial Summary

Patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits.

Clinical Trial Description

After obtaining informed consent, patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits. All subjects will complete a MIDAS questionnaire and allodynia questionnaire at their initial visit. Follow-up visits will be scheduled at 4-6 weeks, 3, 6, 9 and 12 months. In-person follow-up visits will be conducted in the standard fashion of the current physician's practice, with the initial intake conducted by an ophthalmic technician or resident, followed by the physician visit. Telemedicine visits will be conducted by the physician and recorded. Similar information will be gathered in both groups including: current medications, interim medical and headache history (including visits to the ED or hospitalizations for headache), description of headache, response to treatment (including adverse reactions), allergies, blood pressure and weight. Subjects randomized to telemedicine will be asked to have their blood pressure and weight measured within 5 days of their telemedicine session at a location convenient to them. We will record the length of each visit. Subjects in the in-person group, will be queried about travel time, and the total amount of time for the visit, and any activities missed to attend the visit. We will also ask about other costs associated with attending the office visit, such as child care.

At the one-year follow-up visit, subjects will complete the MIDAS, allodynia questionnaire, Modified Group Health Association of America's Consumer Satisfaction scale, and have the opportunity to express their views on the aspect of care received in a semi-structured interview. The follow-up questionnaires may be completed on line (telemedicine group, optional for in-person group) or on paper (in-person group). Headache diaries will be provided on line or may be done on paper, a smartphone, or a computer program of the subject's choosing.

All subjects will be able to access the physician by telephone, using MyChart, or with additional non-study visits as needed.

Subjects will be responsible for the cost of the medications, treatments prescribed, and laboratory monitoring needed for their condition.

Support staff will be available to help set up the video system for subjects assigned to the telemedicine group who are in need of assistance. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01706003
Study type	Observational
Source	University of Texas Southwestern Medical Center
Contact
Status	Completed
Phase
Start date	October 2012
Completion date	October 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06342232` - The Efficacy of Neurofeedback Mindfulness in Migraine Management	N/A
Completed	`NCT02351544` - Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches	N/A
Completed	`NCT00665236` - Craniosacral Therapy in Migraine: A Feasibility Study	N/A
Terminated	`NCT01944059` - Theramine® in the Prevention of Migraine Headache	Phase 4
Terminated	`NCT01629329` - Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine	Phase 4
Completed	`NCT00792636` - A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period	Phase 4
Not yet recruiting	`NCT05536635` - Effect of Breathing Techniques on Migraine Attacks and Severity	N/A
Completed	`NCT00442221` - The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months	Phase 3
Completed	`NCT02057315` - Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine	Phase 1/Phase 2
Completed	`NCT00109083` - A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine	Phase 2
Completed	`NCT02098499` - Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial	Phase 4
Completed	`NCT00714727` - Set Point Acupuncture for Migraines Using a Digital Assistant	Phase 1
Completed	`NCT00434083` - To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches	Phase 3
Completed	`NCT00960245` - Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions	Phase 1
Completed	`NCT02856802` - An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)	Phase 2
Completed	`NCT00355056` - PREMIUM Migraine Trial	N/A
Completed	`NCT01118988` - Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents	N/A
Completed	`NCT00433732` - To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches	Phase 3
Completed	`NCT00750594` - Patent Foramen Ovale in Children With Migraine Headaches	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.